Skip to main content
. Author manuscript; available in PMC: 2016 May 12.
Published in final edited form as: Am J Gastroenterol. 2016 Mar 1;111(5):671–676. doi: 10.1038/ajg.2016.44

Table 1.

Baseline characteristics

Variable NAFLD −CVD NAFLD +CVD P value
Mean age±s.d. (years) 52.3±14.1 61.9±13.1 <0.0001
Gender; no. (%)
 Male 2,652 (51.3%) 1,789 (55.2%) 0.0006
 Female 2,514 (48.7%) 1,454 (44.8%)
Ethnicity; no. (%)
 White 3,399 (87.1%) 2,574 (92.6%) <0.0001
 African American 296 (7.6%) 146 (5.25%)
 Other 206 (5.3%) 60 (2.2%)
BMI±s.d (kg/m2) 33.4±7.6 33.3±10.6 0.30
Obesity; no. (%) 1,747 (33.8%) 1,074 (33.1%) 0.51
Diabetes mellitus; no. (%) 3,340 (64.7%) 2,651 (82.0%) <0.0001
Hypertension; no. (%) 2,946 (57.0%) 2,745 (84.6%) <0.0001
Family history of CVD; no. (%) 3,014 (58.3%) 2,172 (67.0%) <0.0001
Renal failure; no. (%) 363 (7.0%) 546 (16.8%) <0.0001
LDL±s.d. (mg/dl) 112.5±38.2 106.3±38.8 <0.0001
Non-HDL-C±s.d. (mg/dl) 189.7±63.6 182.3±58.8 <0.0001
Albumin±s.d. (g/dl) 3.9±0.69 3.7±0.63 <0.0001
Sodium±s.d. (mmol/l) 139.0±2.9 138.0±2.7 <0.0001
MELD score±s.d. 10.2±5.0 12.3±5.7 <0.0001

BMI, body mass index; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; MELD, Model for End-Stage Liver Disease; NAFLD, nonalcoholic fatty liver disease.